Chengdu Brilliant Pharmaceutical Co., Ltd.
Chengdu Brilliant Pharmaceutical Co., Ltd.
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC | Small Cell Lung Cancer Extensive Stage | Recruiting | Phase 1 | 2026-07-21 | NCT06348797 | |
| A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects | Healthy Participants | Recruiting | Phase 1 | 2025-02-12 | NCT06760455 |